Funding sources Novartis Pharmaceuticals funded this work with an unrestricted grant, but had no role in planning or conducting the project, nor in data collection, interpretation or drafting the manuscript. The work was also supported by an unrestricted gift to the Trustees of the University of Pennsylvania from the Arguild Foundation (J.M.G.), which had no role in the project.
Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors
Article first published online: 30 JUN 2011
© 2011 The Authors. BJD © 2011 British Association of Dermatologists
British Journal of Dermatology
Volume 165, Issue 3, pages 465–473, September 2011
How to Cite
Tennis, P., Gelfand, J.M. and Rothman, K.J. (2011), Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. British Journal of Dermatology, 165: 465–473. doi: 10.1111/j.1365-2133.2011.10363.x
Conflicts of interest This review was supported by an unrestricted grant from Novartis Pharmaceuticals. RTI Health Solutions conducts pharmacoepidemiological research sponsored by Novartis and by Astellas, the manufacturers of topical calcineurin inhibitors. J.M.G. has received grant funding from Novartis to conduct a phase II trial of a biologic for psoriasis.
- Issue published online: 28 AUG 2011
- Article first published online: 30 JUN 2011
- Accepted manuscript online: 5 APR 2011 06:45AM EST
- Accepted for publication 30 March 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.